Proton beams to replace photon beams in radical dose treatments

被引:112
作者
Suit, H [1 ]
Goldberg, S [1 ]
Niemierko, A [1 ]
Trofimov, A [1 ]
Adams, J [1 ]
Paganetti, H [1 ]
Chen, GTY [1 ]
Bortfeld, T [1 ]
Rosenthal, S [1 ]
Loeffler, J [1 ]
Delaney, T [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiat Oncol, Boston, MA 02114 USA
关键词
D O I
10.1080/02841860310017676
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
With proton beam radiation therapy a smaller volume of normal tissues is irradiated at high dose levels for most anatomic sites than is feasible with any photon technique. This is due to the Laws of Physics, which determine the absorption of energy from photons and protons. In other words, the dose from a photon beam decreases exponentially with depth in the irradiated material. In contrast, protons have a finite range and that range is energy dependent. Accordingly, by appropriate distribution of proton energies, the dose can be uniform across the target and essentially zero deep to the target and the atomic composition of the irradiated material. The dose proximal to the target is lower compared with that in photon techniques, for all except superficial targets. This resultant closer approximation of the planning treatment volume (PTV) to the CTV/GTV (grossly evident tumor volume/subclinical tumor extensions) constitutes a clinical gain by definition; i.e. a smaller treatment volume that covers the target three dimensionally for the entirety of each treatment session provides a clinical advantage. Several illustrative clinical dose distributions are presented and the clinical outcome results are reviewed briefly. An important technical advance will be the use of intensity modulated proton radiation therapy, which achieves contouring of the proximal edge of the SOBP (spread out Bragg peak) as well as the distal edge. This technique uses pencil beam scanning. To permit further progressive reductions of the PTV, 4-D treatment planning and delivery is required. The fourth dimension is time, as the position and contours of the tumor and the adjacent critical normal tissues are not constant. A potentially valuable new method for assessing the clinical merits of each of a large number of treatment plans is the evaluation of multidimensional plots of the complication probabilities for each of 'n' critical normal tissues/structures for a specified tumor control probability. The cost of proton therapy compared with that of very high technology photon therapy is estimated and evaluated. The differential is estimated to be approximate to 1.5 provided there were to be no charge for the original facility and that there were sufficient patients for operating on an extended schedule (6-7 days of 14-16 h) with greater than or equal to two gantries and one fixed horizontal beam.
引用
收藏
页码:800 / 808
页数:9
相关论文
共 17 条
  • [1] Proton-beam radiotherapy for early-stage lung cancer
    Bush, DA
    Slater, JD
    Bonnet, R
    Cheek, GA
    Dunbar, RD
    Moyers, M
    Slater, JM
    [J]. CHEST, 1999, 116 (05) : 1313 - 1319
  • [2] Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma
    Egger, E
    Schalenbourg, A
    Zografos, L
    Bercher, L
    Boehringer, T
    Chamot, L
    Goitein, G
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (01): : 138 - 147
  • [3] FALKMER S, 1964, ACTA RADIOL, V59, P33
  • [4] Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme:: results of a phase II prospective trial
    Fitzek, MM
    Thornton, AF
    Rabinov, JD
    Lev, MH
    Pardo, FS
    Munzenrider, JE
    Okunieff, P
    Bussière, M
    Braun, I
    Hochberg, FH
    Hedley-Whyte, ET
    Liebsch, NJ
    Harsh, GR
    [J]. JOURNAL OF NEUROSURGERY, 1999, 91 (02) : 251 - 260
  • [5] EFFECT OF HIGH ENERGY PROTONS ON HUMAN GENITAL CARCINOMA
    FORS, B
    STENSON, S
    LINDELL, A
    LARSSON, B
    NAESLUND, J
    [J]. ACTA RADIOLOGICA-THERAPY PHYSICS BIOLOGY, 1964, 2 (05): : 384 - &
  • [6] The relative costs of proton and X-ray radiation therapy
    Goitein, M
    Jermann, M
    [J]. CLINICAL ONCOLOGY, 2003, 15 (01) : S37 - S50
  • [7] SUPPLEMENTARY TREATMENT OF NASOPHARYNGEAL TUMOURS WITH HIGH ENERGY PROTONS
    GRAFFMAN, S
    JUNG, B
    NOHRMAN, BA
    BERGSTRO.R
    [J]. ACTA RADIOLOGICA-THERAPY PHYSICS BIOLOGY, 1967, 6 (05): : 361 - &
  • [8] Gragoudas E, 2002, ARCH OPHTHALMOL-CHIC, V120, P1665
  • [9] Radiation-induced second cancers: The impact of 3D-CRT and IMRT
    Hall, EJ
    Wuu, CS
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (01): : 83 - 88
  • [10] Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes
    Lomax, AJ
    Cella, L
    Weber, D
    Kurtz, JM
    Miralbell, R
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 55 (03): : 785 - 792